[1]谯小勇,靳松,杨业洲*.多囊卵巢综合征长期并发症早防早治新策略[J].中国计划生育和妇产科,2020,(2):13-18.
点击复制

多囊卵巢综合征长期并发症早防早治新策略
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2020年2期
页码:
13-18
栏目:
多囊卵巢综合征最新指南解读及新领悟专题
出版日期:
2020-02-25

文章信息/Info

作者:
谯小勇靳松杨业洲*
四川大学华西第二医院生殖医学科四川大学华西第二医院出生缺陷与相关妇儿疾病教育部重点实验室
关键词:
多囊卵巢综合征并发症新策略
分类号:
R 71175

参考文献/References:

[1]Fauser BCJM, Tarlatzis BC, Rebar RW, et al. Consensus on women’s health aspects of polycystic ovary syndrome(PCOS): the Amsterdam ESHRE/ASRM-Sponsored 3rd PCOS Consensus Workshop Group [J]. Fertil Steril,2012,97(1):28-38. [2]LI Rong, ZHANG Qiufang, YANG Dongzi, et al. Prevalence of polycystic ovary syndrome in women in China: a large community-based study [J].Human Reproduction,2013,28(9):2562-2569. [3]Teede H J. International evidence-based guideline for the assessment and management of polycystic ovary syndrome.2018[Z], 2018. [4]Bahri Khomami M, Joham A E, Boyle J A, et al. Increased maternal pregnancy complications in polycystic ovary syndrome appear to be independent of obesity-A systematic review, meta-analysis, and meta-regression[J]. Obesity Reviews, 2019,20(12):659-674. [5]Wild R A, Carmina E, Diamanti-kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: a consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society [J]. The Journal of Clinical Endocrinology and Metabolism, 2010, 95(5): 2038-2049. [6]Heida KY, Bots ML, Groot DE, et al. Cardiovascular risk management after reproductive and pregnancy-related disorders:A Dutch multidisciplinary evidence-based guideline [J].Eur J PrevCardiol, 2016,23(17): 1863-1879. [7]Legro R S, Arslanian S A, Ehrmann D A, et al. Diagnosis and treatment of polycystic ovary syndrome: an Endocrine Society clinical practice guideline [J]. The Journal of Clinical Endocrinology and Metabolism, 2013, 98(12): 4565-4592. [8]Brinton LA, Westhoff CL, Scoccia B, et al. Fertility drugs and endometrial cancer risk: results from an extended follow-up of a large infertility cohort [J]. Human Reproduction, 2013, 28(10): 2813-2821. [9]Harris HR, Terry KL. Polycystic ovary syndrome and risk of endometrial, ovarian, and breast cancer:a systematic review [J]. Fertil Res Pract, 2016,2(5): 14. [10]American College of Obstetricians and Gynecologists. ACOG Practice Bulletin No 194: Polycystic Ovary Syndrome [J].Obstetricsand gynecology,2018,131 (6):e 157-e 171. [11]Marin JM,Carrizo SJ,Vicente E, et al. Long-term cardiovascular outcomes in men with obstructive sleep apnoea-hypopnoea with or without treatment with continuous positive airway pressure: an observational study [J]. Lancet,2005,365(9464):1046-1053. [12]Kahal H, Kyrou I,Uthman OA, et al. The prevalence of obstructive sleep apnoea in women with polycystic ovary syndrome: a systematic review and meta-analysis [J].Sleep Breath,2019. [13]Younossi ZM, Koenig AB, Abdelatif D, et al. Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes[J]. Hepatology (Baltimore, Md.), 2016, 64 (1): 73-84. [14]曲中玉, 石玉华, 赵冬妮, 等.肥胖对多囊卵巢综合征患者非酒精性脂肪性肝病的影响 [J].中华医学杂志,2010,90(29): 2036-2039. [15]Ramezani-Binabaj M, Motalebi M, Karimi-Sari H, et al. Are women with polycystic ovarian syndrome at a high risk of Non-Alcoholic fatty liver disease:a Meta-Analysis[J]. Hepatitis Monthly, 2014, 14(11): e 23235. [16]Kumarendran B,O'Reilly MW,Manolopoulos KN,et al. Polycystic ovary syndrome, androgen excess, and the risk of nonalcoholic fatty liver disease in women: A longitudinal study based on a United Kingdom primary care database[J]. PLOS Medicine, 2018, 15(3): 1-20. [17]Cooney LG, Lee I, Sammel MD, et al. High prevalence of moderate and severe depressive and anxiety symptoms in polycystic ovary syndrome:a systematic review and meta-analysis[J]. Human Reproduction,32(5):1075-1091. [18]Zhao SK, Wang JM, Xie Q, et al. Is polycystic ovary syndrome associated with risk of female sexual dysfunction A systematic review and meta-analysis [J].Reprod Biomed Online,2019,38(6):979-989. [19]Lee I,Cooney LG, Saini S, et al. Increased odds ofdisordered eating inpolycystic ovary syndrome: a systematic review and metaanalysis [J].Eat Weight Disord,2019,24(5):787-797. [20]Cesta CE, Mnsson M, Palm C, et al. Polycystic ovary syndrome and psychiatric disorders: Co-morbidity and heritability in a nationwide Swedish cohort [J]. Psychoneuroendocrinology, 2016, 73(11): 196-203. [21]Tay CT, Teede HJ, Hill B, et al. Increased prevalence of eating disorders, low self-esteem, and psychological distress in women with polycystic ovary syndrome: a community-based cohort study[J]. Fertility and Sterility, 2019, 112(2): 353-361. [22]The Rotterdam ESHRE/ASRM-Sponsored PCOS Consensus Workshop Group. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome [J]. Fertil Steril,2004,81(1):19-25. [23]GBD 2016 Alcohol Collaborators. Alcohol use and burden for 195 countries and territories,1990-2016: a systematic analysis for the Global Burden of Disease Study 2016 [J]. Lancet,2018,392(9): 1015-1035. [24]母义明,纪立农,宁光,等.二甲双胍临床应用专家共识(2016年版)[J].中国糖尿病杂志,2016,27(10):871-884. [25]American Diabetes Association Standards of Medical Care in Diabetesd 2019 [J]. Diabetes Care,2019,42:S1~204. [26]Tay CT, JohamAE,HiamDS,et al. Pharmacological and surgical treatment of non reproductive outcomes in polycystic ovary syndrome: An overview ofsystematic reviews [J]. Clinical Endocrinology,2018,89(5):535-553. [27]Morley LC, Tang T, Yasmin E,et al. Insulin-sensitising drugs (metformin, rosiglitazone,pioglitazone,D-chiro-inositol) for women with polycysticovary syndrome, oligoamenorrhoea and subfertility (Review) [J]. Cochrane Database of Systematic Reviews,2017, 29(11): CD003053. [28]Apovian CM, Aronne LJ, Bessesen DH, et al. Pharmacological management of obesity: an endocrine society clinical practice guideline [J]. Journal of Clinical Endocrinology & Metabolism, 2015, 100(2): 342-362. [29]Garvey WT, Mechanick JI, Brett EM, et al. American association of clinical endocrinologists and American college of endocrinology comprehensive clinical practice guldelines for medical care of patients with obesity [J]. Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists, 2016, 22(Suppl 3): 1-203. [30]Martin KA, Anderson RR, Chang RJ, et al. Evaluation and treatment of hirsutism in premenopausal women: An endocrine society clinical practice guideline[J]. Journal of Clinical Endocrinology & Metabolism, 2008, 93(4): 1105-1120. [31]Bibbins-Domingo K, Grossman D C, Curry S J, et al. Statin Use for the Primary Prevention of Cardiovascular Disease in Adults: US Preventive Services Task Force Recommendation Statement [J]. The Journal of the American Medical Association, 2016, 316(19):1997-2007. [32]Karalis DG,Hill AN,Clifton S, et al. The risks of statin use in pregnancy: A systematic review [J]. Journal of Clinical Lipidology, 2016, 10(5): 1081-1090. [33]中华医学会外科学分会甲状腺及代谢外科学组,中国医师协会外科医师分会肥胖和糖尿病外科医师委员会.中国肥胖及2 型糖尿病外科治疗指南(2019 版) [J].中国实用外科杂志,2019,39(4):301-306.

相似文献/References:

[1]王立.药物流产后阴道持续出血清宫时机选择——附74例分析[J].中国计划生育和妇产科,2009,(06):0.
 WANG Li The peoples hospital of Henggang region,Shenzhen city,Shenzhen Guangdong 8,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2009,(2):0.
[2]喻海芬,熊毅刚.腹腔镜诊治计划生育手术并发症32例临床分析[J].中国计划生育和妇产科,2009,(06):0.
[3]姜荣华,钟小英,潘萍,等.61例多囊卵巢综合征妇女行供精人工授精结局分析[J].中国计划生育和妇产科,2011,(04):0.
 JIANG Rong-hua,ZHONG Xiao-ying,PAN Ping.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(2):0.
[4]辛亚维,李奕,王建梅,等.人工流产术后即时口服避孕药妈富隆的临床观察[J].中国计划生育和妇产科,2012,(01):0.
 XIN Ya-wei,LI Yi,WANG Jian-mei*,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[5]罗春艳,刘洁.早发型重度子痫前期39例临床特点分析[J].中国计划生育和妇产科,2012,(01):0.
 LUO Chun-yan,LIU Jie.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[6]李玲.阴式全子宫切除术230例近远期并发症分析[J].中国计划生育和妇产科,2012,(03):0.
 LI Ling.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[7]李力,韩建.重视剖宫产并发症的预防[J].中国计划生育和妇产科,2012,(04):0.
 LI Li,HAN Jian.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[8]李天蓉,赵丽,马彦,等.皮下埋植剂取出标准化操作程序临床应用的效果观察[J].中国计划生育和妇产科,2012,(04):0.
 LI Tian-rong*,ZHAO Li,MA Yan,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2012,(2):0.
[9]袁媛,周灿权.控制性超排卵中卵巢高反应与辅助生殖的安全运行[J].中国计划生育和妇产科,2013,(01):0.
 YUAN Yuan,ZHOU Can-quan Reproductive Research Center,The First Affiliated Hospital of Sun Yat-sen University,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.
[10]闫少甫.瘢痕子宫妊娠重复剖宫产并发症的对比分析[J].中国计划生育和妇产科,2013,(03):0.
 YAN Shao - fu.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(2):0.

备注/Memo

备注/Memo:
“十三五”国家重点研发计划;“生殖疾病防治规范化体系建立”(项目编号:2018YFC1002100)
更新日期/Last Update: 2020-02-25